These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36220587)

  • 1. CD8
    Castoldi A; Lee J; de Siqueira Carvalho D; Souto FO
    Biochim Biophys Acta Mol Basis Dis; 2023 Jan; 1869(1):166565. PubMed ID: 36220587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Regulation of CD8
    Zheng Y; Wang X; Huang M
    Antioxid Redox Signal; 2022 Dec; 37(16-18):1234-1253. PubMed ID: 35345890
    [No Abstract]   [Full Text] [Related]  

  • 3. The Emerging Role of CD8
    Corgnac S; Boutet M; Kfoury M; Naltet C; Mami-Chouaib F
    Front Immunol; 2018; 9():1904. PubMed ID: 30158938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response.
    Reiser J; Banerjee A
    J Immunol Res; 2016; 2016():8941260. PubMed ID: 27314056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8
    Farhood B; Najafi M; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunometabolic Checkpoints of Treg Dynamics: Adaptation to Microenvironmental Opportunities and Challenges.
    Pacella I; Piconese S
    Front Immunol; 2019; 10():1889. PubMed ID: 31507585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell immunometabolism against cancer.
    Jiang S; Yan W
    Cancer Lett; 2016 Nov; 382(2):255-258. PubMed ID: 27664755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8
    Mastelic-Gavillet B; Navarro Rodrigo B; Décombaz L; Wang H; Ercolano G; Ahmed R; Lozano LE; Ianaro A; Derré L; Valerio M; Tawadros T; Jichlinski P; Nguyen-Ngoc T; Speiser DE; Verdeil G; Gestermann N; Dormond O; Kandalaft L; Coukos G; Jandus C; Ménétrier-Caux C; Caux C; Ho PC; Romero P; Harari A; Vigano S
    J Immunother Cancer; 2019 Oct; 7(1):257. PubMed ID: 31601268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin Reprograms Tryptophan Metabolism to Stimulate CD8+ T-cell Function in Colorectal Cancer.
    Huang X; Sun T; Wang J; Hong X; Chen H; Yan T; Zhou C; Sun D; Yang C; Yu T; Su W; Du W; Xiong H
    Cancer Res; 2023 Jul; 83(14):2358-2371. PubMed ID: 37195082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic cross-talk between cancer and T cells.
    Cadenas-De Miguel S; Lucianer G; Elia I
    Trends Biochem Sci; 2023 Jul; 48(7):597-609. PubMed ID: 37080875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunometabolism in the Bladder Cancer Microenvironment.
    Fattahi MJ; Haghshenas MR; Ghaderi A
    Endocr Metab Immune Disord Drug Targets; 2022; 22(12):1201-1216. PubMed ID: 34983357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing CD8
    Zhang Y; Kurupati R; Liu L; Zhou XY; Zhang G; Hudaihed A; Filisio F; Giles-Davis W; Xu X; Karakousis GC; Schuchter LM; Xu W; Amaravadi R; Xiao M; Sadek N; Krepler C; Herlyn M; Freeman GJ; Rabinowitz JD; Ertl HCJ
    Cancer Cell; 2017 Sep; 32(3):377-391.e9. PubMed ID: 28898698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microenvironment-driven metabolic adaptations guiding CD8
    Park J; Hsueh PC; Li Z; Ho PC
    Immunity; 2023 Jan; 56(1):32-42. PubMed ID: 36630916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic Control of CD8
    Zhang L; Romero P
    Trends Mol Med; 2018 Jan; 24(1):30-48. PubMed ID: 29246759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8-mediated type 1 antitumor responses selectively modulate endogenous differentiated and nondifferentiated T cell localization, activation, and function in progressive breast cancer.
    Dobrzanski MJ; Reome JB; Hylind JC; Rewers-Felkins KA
    J Immunol; 2006 Dec; 177(11):8191-201. PubMed ID: 17114496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-cell-derived fumarate suppresses the anti-tumor capacity of CD8
    Cheng J; Yan J; Liu Y; Shi J; Wang H; Zhou H; Zhou Y; Zhang T; Zhao L; Meng X; Gong H; Zhang X; Zhu H; Jiang P
    Cell Metab; 2023 Jun; 35(6):961-978.e10. PubMed ID: 37178684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Adrenergic Stress Contributes to Metabolic Dysfunction and an Exhausted Phenotype in T Cells in the Tumor Microenvironment.
    Qiao G; Chen M; Mohammadpour H; MacDonald CR; Bucsek MJ; Hylander BL; Barbi JJ; Repasky EA
    Cancer Immunol Res; 2021 Jun; 9(6):651-664. PubMed ID: 33762351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Mechanisms Underpinning Immunometabolic Reprogramming: How the Wind Changes during Cancer Progression.
    Flati I; Di Vito Nolfi M; Dall'Aglio F; Vecchiotti D; Verzella D; Alesse E; Capece D; Zazzeroni F
    Genes (Basel); 2023 Oct; 14(10):. PubMed ID: 37895302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sculpting tumor microenvironment with immune system: from immunometabolism to immunoediting.
    Yu YR; Ho PC
    Clin Exp Immunol; 2019 Aug; 197(2):153-160. PubMed ID: 30873592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDAC9 deficiency promotes tumor progression by decreasing the CD8
    Ning Y; Ding J; Sun X; Xie Y; Su M; Ma C; Pan J; Chen J; Jiang H; Qi C
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32554611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.